A Legacy of Continuous Innovation in Viral Load Monitoring

At Roche, we stand united to work together toward a common goal — as researchers, diagnostic labs and clinicians — to improve treatment outcomes for patients and eradicate a common adversary: infectious viruses.

Our HIV-1, HCV, HBV, and CMV viral load assays are the most clinically validated, with over 142 million viral load tests performed worldwide1, and have been at the forefront of pharmaceutical and clinical research. This creates a unique link between clinical trials and clinical practice that no other manufacturer can offer.2

Proven Consistent Reliability

The #1 choice that patients depend on

Based on the industry standard TaqMan® real-time PCR technology, the virology systems offer many advantages for the molecular diagnostics laboratory, including triple layered state of the art contamination control appropriate for high titer specimens.

All our systems and assays are backed up with excellent service and support from a trusted partner for Virology assays on the COBAS® AmpliPrep/COBAS® TaqMan® System and cobas® 6800/8800 Systems.

Go with the gold standard in Viral Load testing

When you choose Roche virology, you can expect:

  • Market-leading accuracy and reliability
  • 8th Generation HIV-1 assay
  • An unmatched legacy of innovating industry "firsts"
  • The assurance you’re using the same high-performance technology used in clinical trials
  • Transformative innovations on the cobas® 6800/8800 systems
  • An ongoing investment in future assay development

Redefining HCV Viral Load Monitoring

The cobas® HCV test is the first and only FDA approved HCV RNA viral load test for use as an aid in diagnosis of active HCV infection.3

Quantitate HBV DNA Viral Loads with Confidence

The cobas® HBV test is a real-time PCR test that provides quantitative HBV DNA results that have an impact on the workflow in your laboratory without compromising the results you rely on.4

Gold Standard in HIV-1 Molecular Testing

The cobas® HIV-1 test for viral load monitoring has a unique dual target design, amplifying two separate regions of the HIV-1 genome. The test provides confidence in results for patients living with the
HIV-1 virus.5

Standardized for CMV Testing for Patients

The cobas® CMV test is a fully automated FDA-approved CMV test that delivers the benefits of standardization for clinical decision making, while providing improved efficiencies the laboratory truly needs.6

1. Data on file. Roche Diagnostics, September 2015.
2. See Drug Manufacturer Package Inserts
3. cobas® HCV Package Insert 07175418001-0lEN ver 1.0
4. cobas® HBV Package Insert 07000979190 ver 1.0
5. cobas® HIV Package Insert 07175493001-0lEN ver 1.0
6. cobas® CMV Package Insert 04902025190 ver 4.0